Anastomotic Leakage after Gastrectomy for Gastric Cancer
Journal of Gastrointestinal and Liver Diseases · 22.12.2023 · 32 (4) · 526-535
DOI: 10.15403/jgld-5238 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 22.12.2023. Verfasst von Radu Ion Seicean und 5 weiteren Autor:innen. Beteiligte Einrichtung: Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; 2) First Surgical Clinic, Cluj-Napoca, Romania. . rseicean@yahoo.com. Hauptthemen laut MEDLINE: Stomach Neoplasms, Laparoscopy. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Anastomotic leakage (AL) constitutes a prominent cause of significant morbidity following gastrectomy for gastric cancer. The manifestation of AL typically occurs within 7 to 10 days post-surgery, with reported incidence rates of 5.8-6.7% for open gastrectomy and 3.3-4.1% for laparoscopic gastrectomy. Various predisposing risk factors have been identified, including the individual nutritional status (excluding obesity) and preoperative corticotherapy. Interestingly, the administration of neoadjuvant therapies appears to reduce the AL occurrence. In the context of distal gastrectomies, the rates of AL are comparable between laparoscopic, robotic, and open approaches. The total gastrectomies have higher AL rate compared to distal gastrectomies, which are considered the preferred approach. Prophylactic drainage measures have not demonstrated efficacy in preventing AL. As for postoperative management, conservative treatment is indicated for patients presenting with mild clinical symptoms and increased inflammatory blood tests. This approach involves fasting, enteral or parenteral nutrition, administration of antibiotics, and percutaneous drainage. For small AL, endoscopic therapies such as stents, vacuum therapy, clips, suturing devices, and injections are appropriate treatment options. In cases of high-volume fistulas, severe sepsis or failure of previous therapies, surgical reoperation becomes the ultimate solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; 2) First Surgical Clinic, Cluj-Napoca, Romania. . rseicean@yahoo.com.
- Institute of Oncology, Department of Medical Oncology, Bucharest, Romania. danusia.puscasu@gmail.com.
- Emergency County Hospital Cluj-Napoca, Romania. gheorghiu.andrew@gmail.com.
- Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca; UBB Med., Babes Bolyai University, Cluj-Napoca, Romania. cristinapojoga@yahoo.com.
- Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania. andradaseicean@gmail.com.
- Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; 2) First Surgical Clinic, Cluj-Napoca, Romania. george.dindelegan@gmail.com.
Zitieren
APA
Seicean, R. I., Puscasu, D., Gheorghiu, A., Pojoga, C., Seicean, A., & Dindelegan, G. (2023). Anastomotic Leakage after Gastrectomy for Gastric Cancer. Journal of Gastrointestinal and Liver Diseases, 32(4), 526-535. https://doi.org/10.15403/jgld-5238
Vancouver
Seicean RI, Puscasu D, Gheorghiu A, Pojoga C, Seicean A, Dindelegan G. Anastomotic Leakage after Gastrectomy for Gastric Cancer. Journal of Gastrointestinal and Liver Diseases. 2023;32(4):526-535. doi:10.15403/jgld-5238
BibTeX
@article{Seicean2023,
author = {Seicean, Radu Ion and Puscasu, Danusia and Gheorghiu, Andrei and Pojoga, Cristina and Seicean, Andrada and Dindelegan, George},
title = {Anastomotic Leakage after Gastrectomy for Gastric Cancer},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2023},
volume = {32},
number = {4},
pages = {526--535},
doi = {10.15403/jgld-5238}
}
EUVIMED